Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 107Precursor Cell Lymphoblastic Leukemia-Lymphoma 40Recurrence 20Leukemia 18Burkitt Lymphoma 18Lymphoma 17Neoplasms, Plasma Cell 13Lymphoma, Non-Hodgkin 13Nausea 12Lymphoma, Mantle-Cell 12Vomiting 11Waldenstrom Macroglobulinemia 10Breast Neoplasms 10Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9Neoplasms 9Lymphoma, Follicular 9Immunoglobulin Light-chain Amyloidosis 8Lymphoma, B-Cell, Marginal Zone 7Hodgkin Disease 7Amyloidosis 7Smoldering Multiple Myeloma 6Lymphoma, Large B-Cell, Diffuse 6Leukemia, Myeloid, Acute 6Leukemia, Lymphocytic, Chronic, B-Cell 6Prostatic Neoplasms 5Leukemia, Biphenotypic, Acute 5Hematologic Neoplasms 5Sezary Syndrome 4Mycosis Fungoides 4Lymphoma, T-Cell, Cutaneous 4

Interventions

Lenalidomide 3Bortezomib 3Dexamethasone 2vandetanib 1umbralisib 1ublituximab 1marizomib 1durvalumab 1carotuximab 1avelumab 1Zoledronic Acid 1Vitamin D 1Transplantation, Autologous 1Tamoxifen 1Standard of Care 1Practice Guidelines as Topic 1Palliative Care 1Oxaliplatin 1Melphalan 1Leucovorin 1Irinotecan 1Granulocyte Colony-Stimulating Factor 1Gemcitabine 1Folfox protocol 1Fluorouracil 1Filgrastim 1Cyclophosphamide 1Cisplatin 1Carboplatin 1Calcium Dobesilate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Disease Progression × Calcium Dobesilate × Clear all
NCT01109004 2021-12-09

BMT CTN 0702

National Heart, Lung, and Blood Institute (NHLBI)

Phase 3 Completed
758 enrolled 21 charts
Plasma cell

Hematologic Diseases, Multiple Myeloma, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡